Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Outcomes in allogeneic hematopoietic stem cell transplantation for Fanconi anemia.

Bone marrow transplantation·2025

Same author

Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Español de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee.

Cytotherapy·2024

Same author

[Gastrointestinal involvement in Langerhans cell histiocytosis].

Anales de pediatria (Barcelona, Spain : 2003)·2015

Same author

[Body plethysmography (I): Standardisation and quality criteria].

Anales de pediatria (Barcelona, Spain : 2003)·2015

Same author

[Validation of a Spanish version of the Childhood Asthma Control Test (Sc-ACT) for use in Spain].

Anales de pediatria (Barcelona, Spain : 2003)·2015

Same author

[Measurement of CO diffusion capacity (II): Standardization and quality criteria].

Anales de pediatria (Barcelona, Spain : 2003)·2014

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

Orthotopic Left Lung Transplantation in Rats

Orthotopic Left Lung Transplantation in Rats

Published on: July 3, 2025

[Lung function changes after haematopoietic stem cell transplantation].

T de la Calle Cabrera¹, J R Villa Asensi, M González Vicent

¹Servicios de Neumofisiología, Hospital Infantil Universitario Niño Jesús, Madrid, Spain. teresacalle1@hotmail.com

Anales De Pediatria (Barcelona, Spain : 2003)

|January 9, 2009

Summary

Children undergoing hematopoietic stem cell transplantation (HSCT) often experience early lung function abnormalities. While lung function partially recovers by 24 months, it may not reach pre-transplant levels.

More Related Videos

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP

Published on: February 14, 2022

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Related Experiment Videos

Last Updated: Jun 26, 2026

Orthotopic Left Lung Transplantation in Rats

Orthotopic Left Lung Transplantation in Rats

Published on: July 3, 2025

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP

Published on: February 14, 2022

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Area of Science:

Pediatric Pulmonology
Hematology
Transplantation Medicine

Background:

Hematopoietic stem cell transplantation (HSCT) is a critical treatment for various pediatric conditions.
Pulmonary complications are a significant concern following HSCT in children.
Understanding lung function changes post-HSCT is crucial for patient management.

Purpose of the Study:

To evaluate lung function abnormalities in children after HSCT.
To compare pulmonary outcomes between autologous and allogenic HSCT.
To assess the temporal pattern of lung function recovery post-transplantation.

Main Methods:

Prospective observational study including 93 children undergoing HSCT (47 autologous, 46 allogenic).
Lung function tests (FEV1, FEV1/FVC, TLC, DLCO) performed pre-HSCT and at 2, 6, 12, and 24 months post-HSCT.
Paired Student's t-test used for statistical analysis.

Main Results:

Significant reductions in FEV1/FVC, TLC, and DLCO observed at 2 months post-HSCT compared to baseline.
Lung function showed gradual improvement from 6 months but did not fully recover by 24 months.
No major differences in lung function between autologous and allogenic HSCT, except for lower FEV1/FVC in allogenic at 6 months.

Conclusions:

A substantial proportion of children develop early pulmonary abnormalities after HSCT.
Pulmonary function demonstrates partial recovery by 24 months post-transplantation.
Close monitoring of lung function is essential for pediatric HSCT recipients.